| Goodman Group (GMG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$61,160 |
Dispatch of 30 June 2025 Distribution
|
26 Aug 2025 11:08AM |
$34.330 |
$29.910 |
fallen by
12.88%
|
|
| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$159 |
Strong investment portfolio performance, FF full year div
|
26 Aug 2025 11:07AM |
$0.880 |
$1.070 |
risen by
21.59%
|
|
WAA - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Active Limited achieved strong investment portfolio performance for the financial year ended 30 June 2022.
- A fully franked full-year dividend was declared for shareholders.
- Effective portfolio management and stock selection attributed as key drivers of performance.
- Company demonstrated resilience and value delivery despite volatile market conditions.
- Emphasis placed on maintaining a robust investment strategy for future market challenges.
- WAA reinforced its track record of capital growth and income for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$373 |
FY25 Results Webcast and Date of AGM
|
26 Aug 2025 11:03AM |
$0.210 |
$0.210 |
fallen by
0%
|
|
| Elanor Commercial Property Fund (ECF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
- |
Correction to Announcement - Appendix 4E
|
26 Aug 2025 11:01AM |
$0.703 |
$0.575 |
fallen by
18.15%
|
|
| Andromeda Metals Limited (ADN) ORDINARY FULLY PAID |
Materials |
$35 |
Notification of cessation of securities - ADN
|
26 Aug 2025 11:01AM |
$0.012 |
$0.008 |
fallen by
37.50%
|
|
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$50 |
Investor Webinar Notification - FY25 Results
|
26 Aug 2025 10:59AM |
$0.089 |
$0.073 |
fallen by
17.98%
|
|
| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$159 |
Appendix 4E and Annual Report
|
26 Aug 2025 10:55AM |
$0.880 |
$1.070 |
risen by
21.59%
|
|
WAA - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Active Limited released its Appendix 4E and Annual Report for the year ended 30 June 2023.
- The company reported on its financial performance, including net profit, earnings per share, and dividends.
- Investment strategy centers on actively managed portfolios of undervalued growth companies listed on the ASX.
- Strong focus on delivering consistent dividends to shareholders.
- Directors' report covers corporate governance, board meetings, remuneration, and management of risks.
- Financial statements include profit or loss, financial position, cash flows, and equity changes.
- Auditor’s report is included, affirming compliance with accounting standards and regulations.
- Remuneration report details executive and director compensation policies.
- The report details risk management, internal controls, and compliance processes.
- Company objectives include capital growth and regular income for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$316 |
FY25 Key Financial Results and Annual Report
|
26 Aug 2025 10:55AM |
$0.130 |
$0.750 |
risen by
476.92%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported FY25 financial results including revenue, expenses, and profit/loss figures.
- Provided updates on the development and commercialization of dendrimer-based products, such as VivaGel and DEP® programs.
- Outlined progress in research, development, and clinical trials for key pipeline assets.
- Described new and ongoing strategic collaborations and partnerships.
- Highlighted achievements in regulatory approvals and market entries.
- Detailed capital management activities and cash flow status.
- Presented governance structures and risk management approaches.
- Discussed future outlook and plans for continued growth and pipeline advancement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Claremont Global Fund (Hedged) (Managed Fund) (CGHE) CLAREMONT GLOBAL FUND (HEDGED) ACTIVE ETF |
Financials |
$36 |
Quarterly Portfolio Disclosure - June 2025
|
26 Aug 2025 10:47AM |
$1.780 |
$1.390 |
fallen by
21.91%
|
|
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$50 |
Neurizon to present Q4 updates to Shareholders
|
26 Aug 2025 10:47AM |
$0.155 |
$0.065 |
fallen by
58.06%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$316 |
2025 Annual Report
|
26 Aug 2025 10:47AM |
$0.130 |
$0.750 |
risen by
476.92%
|
|
| Claremont Global Fund (Managed Fund) (CGUN) CLAREMONT GLOBAL FUND ACTIVE ETF |
Financials |
$50 |
Quarterly Portfolio Disclosure - June 2025
|
26 Aug 2025 10:45AM |
$1.690 |
$1.370 |
fallen by
18.93%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$316 |
2025 Appendix 4E Preliminary Financial Report
|
26 Aug 2025 10:42AM |
$0.130 |
$0.750 |
risen by
476.92%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma Holdings Limited released its 2025 Appendix 4E Preliminary Financial Report.
- The financial year ended 30 June 2025 is covered in the report.
- Report includes detailed revenue, expenses, and net loss/profit figures.
- Highlights product development progress, especially with VivaGel and DEP technologies.
- Details on regulatory submissions, product launches, and commercial partnerships are provided.
- Reports on R&D investment and cash flow for the financial year.
- Addresses significant subsequent events after the reporting period.
- Discusses company risk factors and mitigations.
- Provides outlook and strategy for the upcoming year, focusing on market expansion and collaborations.
- Emphasizes ongoing and future collaborations with pharmaceutical partners and market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$149 |
ACW pharmacokinetics trial success
|
26 Aug 2025 10:41AM |
$0.028 |
$0.040 |
risen by
42.86%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen Medical Limited successfully completed a pharmacokinetic trial for Xanamem.
- New Xanamem tablet formulations showed favorable and consistent pharmacokinetic profiles.
- The results support once-daily dosing and improved patient convenience.
- Findings represent a significant milestone in Xanamem's clinical development.
- The trial outcome supports ongoing and future clinical studies for neurodegenerative diseases.
- Actinogen reaffirms commitment to developing therapies for cognitive impairment and neuropsychiatric symptoms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$251 |
IMB - Cleansing Notice on Exercise of Warrants
|
26 Aug 2025 10:34AM |
$0.670 |
$0.610 |
fallen by
8.96%
|
|
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$373 |
Change in substantial holding Ian Ferrier
|
26 Aug 2025 10:33AM |
$14.320 |
$11.740 |
fallen by
18.02%
|
|
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$373 |
Change of Director's Interest Notice Ian Ferrier
|
26 Aug 2025 10:31AM |
$14.320 |
$11.740 |
fallen by
18.02%
|
|
| Elanor Commercial Property Fund (ECF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
- |
FY25 Results Presentation
|
26 Aug 2025 10:29AM |
$0.703 |
$0.575 |
fallen by
18.15%
|
|
| Elanor Commercial Property Fund (ECF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
- |
Update - Dividend/Distribution - ECF
|
26 Aug 2025 10:27AM |
$0.703 |
$0.575 |
fallen by
18.15%
|
|
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$245 |
Update - Sen. Murkowski Visit Solidifies Support for Estelle
|
26 Aug 2025 10:27AM |
$0.300 |
$0.535 |
risen by
78.33%
|
|
| Kula Gold Limited (KGD) ORDINARY FULLY PAID |
Materials |
- |
Change of Director's Interest Notice
|
26 Aug 2025 10:26AM |
$0.008 |
$0.080 |
risen by
966.67%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$251 |
Notification of cessation of securities - IMB
|
26 Aug 2025 10:22AM |
$0.670 |
$0.610 |
fallen by
8.96%
|
|
| HighCom Limited (HCL) ORDINARY FULLY PAID |
Industrials |
$16 |
Briefing Notification - Investor Call - FY25 Results
|
26 Aug 2025 10:22AM |
$0.390 |
$0.110 |
fallen by
71.79%
|
|
| Havilah Resources Limited (HAV) ORDINARY FULLY PAID |
Materials |
$253 |
Advancing South Australia's Next Major Copper Province
|
26 Aug 2025 10:21AM |
$0.170 |
$0.715 |
risen by
320.59%
|
|
HAV - Price-sensitive ASX Announcement
Full Release
Key Points
- Havilah Resources Limited is advancing the development of South Australia's next major copper province.
- The company holds 100% ownership of the Kalkaroo project, one of Australia’s largest undeveloped open pit copper-gold deposits, offering significant exploration upside.
- Havilah’s broader project portfolio includes the Mutooroo Project and other exploration tenements in the Curnamona Copperbelt.
- The company has a clear vision to become a significant copper producer, leveraging South Australia’s strategic location, established infrastructure, and supportive government policies.
- Recent efforts have focused on progressing Kalkaroo towards development readiness, including environmental approvals, mining lease, and final feasibility studies.
- Copper is highlighted as a critical metal for the global energy transition, and Kalkaroo could play a vital role in providing future supply.
- Havilah acknowledges the importance of ESG (Environmental, Social, and Governance) practices and is committed to responsible and sustainable project development.
- Current strategies involve engaging with potential partners and investors to secure funding for project advancement.
- Exploration and resource expansion activities continue to demonstrate the region's copper potential and further opportunities for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gateway Mining Limited (GML) ORDINARY FULLY PAID |
Materials |
$110 |
Reinstatement to Quotation
|
26 Aug 2025 10:20AM |
$0.028 |
$0.048 |
risen by
69.64%
|
|
GML - Price-sensitive ASX Announcement
Full Release
Key Points
- Gateway Mining Limited (GML) securities to be reinstated to quotation on ASX effective 14 June 2024.
- Reinstatement follows completion of required capital raising and compliance with ASX listing rules.
- Holding statements have been despatched to shareholders.
- The company has satisfied all conditions set by the ASX for reinstatement.
- Background information provided on the suspension and procedural steps for reinstatement.
- Details outlined regarding GML's current activities and recent company developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
